|
|
Volumn 8, Issue 12, 2009, Pages 917-918
|
|
Targeting RNA: An emerging hope for treating muscular dystrophy
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTISENSE OLIGONUCLEOTIDE;
ATALUREN;
AVI 4658;
CARDIAC AGENT;
CYTOSKELETON PROTEIN;
DYSTROPHIN;
PRO 051;
RNA;
STEROID;
UNCLASSIFIED DRUG;
VIRUS VECTOR;
ABSENCE OF SIDE EFFECTS;
ARTIFICIAL VENTILATION;
BECKER MUSCULAR DYSTROPHY;
CELL MEMBRANE;
CLINICAL TRIAL;
CYSTIC FIBROSIS;
DEATH;
DRUG MARKETING;
DRUG MECHANISM;
DUCHENNE MUSCULAR DYSTROPHY;
EXON;
GENE DELETION;
GENE EXPRESSION;
GENE MUTATION;
GENE TARGETING;
HEMOPHILIA;
HUMAN;
IMMOBILIZATION;
LICENSING;
MUSCLE CELL;
MUSCLE STRENGTH;
MUSCULAR DYSTROPHY;
NOTE;
PRIORITY JOURNAL;
STOP CODON;
UNSPECIFIED SIDE EFFECT;
VIRAL GENE DELIVERY SYSTEM;
VIRAL GENE THERAPY;
X CHROMOSOME LINKED DISORDER;
GENETIC TRANSCRIPTION;
GENETICS;
METABOLISM;
METHODOLOGY;
MUTATION;
PROTEIN SYNTHESIS;
GENE TARGETING;
HUMANS;
MUSCULAR DYSTROPHY, DUCHENNE;
MUTATION;
OLIGONUCLEOTIDES, ANTISENSE;
PROTEIN BIOSYNTHESIS;
RNA;
TRANSCRIPTION, GENETIC;
|
|
EID: 73449091898
PISSN: 14741776
EISSN: 14741784
Source Type: Journal
DOI: 10.1038/nrd3069 Document Type: Note |
|
Times cited : (8)
|
|
References (0)
|